| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $1.1 (Miss by $-0.65) |
| EPS GAAP Actual | $1.1 (Miss by $-0.65) |
| Revenue Actual | $4.23406B |
| Revenue Surprise | Beat by $4234.06M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $4.29213 |
| EPS GAAP Estimate | $4.29213 |
| Revenue Estimate | $5.135437457B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 15.55 | 7.47 | 14.72374 | 16.28699 | 2 |
| Dec 2026 | 13.65 | 8.51 | 13.17893 | 14.196 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.67 | -2.31892 | 4.23406B | -5.25% | -844.11M |
| FQ1 2025 (Mar 2025) | 0.85 | 0.85 | 3.6575B | -6.39% | 3657.5M |
| FQ4 2024 (Dec 2024) | 1.66 | 1.66 | 3.8203B | -8.65% | 3820.3M |
| FQ3 2024 (Sep 2024) | 2.45 | 2.45 | 4.23249B | -7.13% | 4232.49M |
| FQ2 2024 (Jun 2024) | 2.89 | 2.89 | 4.45634B | -1.63% | 4456.34M |
| FQ1 2024 (Mar 2024) | 2.12 | 2.12 | 3.89135B | 0.21% | 3891.35M |
| FQ4 2023 (Dec 2023) | 2.83 | 2.83 | 4.15086B | -4.98% | 4150.86M |
| FQ3 2023 (Sep 2023) | 3.62 | 3.62 | 4.53426B | -27.07% | 4534.26M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
4.29213
Consensus Revenue Estimates
5.135437457B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.95 | -- | 3.71894 | 4.3348 | 4 |
| FQ3 2027 (Sep 2027) | 4.23 | -- | 3.98256 | 4.64208 | 3 |
| FQ2 2027 (Jun 2027) | 4.37 | -- | 4.11437 | 4.79572 | 4 |
| FQ1 2027 (Mar 2027) | 3.02 | -- | 2.84334 | 3.3142 | 3 |
| FQ4 2026 (Oct 2026) | 4.565 | -- | 4.44224 | 4.73154 | 3 |
| FQ3 2026 (Jul 2026) | 4.1132 | -- | 4.00259 | 4.26326 | 3 |
| FQ2 2026 (Jun 2026) | 4.1132 | 59.4 | 4.00415 | 4.26489 | 3 |
| FQ1 2026 (Mar 2026) | 2.4164 | 64.82 | 2.35233 | 2.50551 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 4.76B | -- | 4.55B | 5.12B | 9 |
| FQ3 2027 (Sep 2027) | 5.04B | -- | 4.82B | 5.42B | 9 |
| FQ2 2027 (Jun 2027) | 5.25B | -- | 5.01B | 5.64B | 9 |
| FQ1 2027 (Mar 2027) | 4.46B | -- | 4.26B | 4.79B | 9 |
| FQ4 2026 (Oct 2026) | 5.37B | -- | 5.26B | 5.52B | 8 |
| FQ3 2026 (Jul 2026) | 5.41B | -- | 5.3B | 5.57B | 5 |
| FQ2 2026 (Jun 2026) | 5.41B | 21.79 | 5.3B | 5.57B | 5 |
| FQ1 2026 (Mar 2026) | 4.26B | 14.04 | 4.17B | 4.38B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 3.98892 | 1.67 | -2.31892 | -138.86% |
| FQ1 2025 (Mar 2025) | 0.85 | 0.85 | 100% | |
| FQ4 2024 (Dec 2024) | 1.66 | 1.66 | 100% | |
| FQ3 2024 (Sep 2024) | 2.45 | 2.45 | 100% | |
| FQ2 2024 (Jun 2024) | 2.89 | 2.89 | 100% | |
| FQ1 2024 (Mar 2024) | 2.12 | 2.12 | 100% | |
| FQ4 2023 (Dec 2023) | 2.83 | 2.83 | 100% | |
| FQ3 2023 (Sep 2023) | 3.62 | 3.62 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $5.08B | $4.23B | $-844.11M | -19.94% |
| FQ1 2025 (Mar 2025) | $0B | $3.66B | $3657.5M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $3.82B | $3820.3M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $4.23B | $4232.49M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $4.46B | $4456.34M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.89B | $3891.35M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $4.15B | $4150.86M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $4.53B | $4534.26M | 100% |